Table: Daiichi - 9-MTH parent results
Table: Daiichi - 6-MTH parent results
Table: Daiichi - Q1 parent results
Table: Daiichi -2024/25 parent results
Table: Daiichi - 9-MTH parent results
Table: Daiichi - 6-MTH parent results
Table: Daiichi - Q1 parent results
IHH Healthcare's damages against Daiichi could reach $1.25 bln, expert report says (updated)
To Buy Back Up To 0.88% Own Shares Worth 150 Million Yen
Table: Daiichi -2023/24 parent results
Table: Daiichi - 9-MTH parent results
Table: Daiichi - 6-MTH parent results
Daiichi invests 1 bln eur near Munich to make precision cancer drugs
Table: Daiichi - Q1 parent results
Esperion Therapeutics rises as BofA raises PT
MacroGenics surges as Citigroup upgrades to 'buy', lifts PT
Table: Daiichi -2022/23 parent results
EU regulator backs AstraZeneca and Daiichi's lung cancer drug (updated)
Table: Daiichi - 9-MTH parent results